Page last updated: 2024-08-17

carbostyril and Respiratory Syndrome, Acute, Severe

carbostyril has been researched along with Respiratory Syndrome, Acute, Severe in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bates, P; Diamond, SL; Greenbaum, DC; Huryn, DM; Jing, H; Kaletsky, RL; Myers, MC; Purvis, JE; Shah, PP; Smith, AB; Wang, T	1

Other Studies

1 other study(ies) available for carbostyril and Respiratory Syndrome, Acute, Severe

Article	Year
A small-molecule oxocarbazate inhibitor of human cathepsin L blocks severe acute respiratory syndrome and ebola pseudotype virus infection into human embryonic kidney 293T cells. Molecular pharmacology, 2010, Volume: 78, Issue:2 Topics: Antiviral Agents; Cathepsin L; Cell Line; Cysteine Proteinase Inhibitors; Hemorrhagic Fever, Ebola; Humans; Kinetics; Quinolines; Quinolones; Severe Acute Respiratory Syndrome	2010

Article

Year

A small-molecule oxocarbazate inhibitor of human cathepsin L blocks severe acute respiratory syndrome and ebola pseudotype virus infection into human embryonic kidney 293T cells.

Molecular pharmacology, 2010, Volume: 78, Issue:2

Topics: Antiviral Agents; Cathepsin L; Cell Line; Cysteine Proteinase Inhibitors; Hemorrhagic Fever, Ebola; Humans; Kinetics; Quinolines; Quinolones; Severe Acute Respiratory Syndrome

2010